期刊文献+

微孔膜渗透泵型胶囊的制备和释药因素研究 被引量:3

Preparation of porous membrane osmotic pump capsules and investigation on their release behavior
下载PDF
导出
摘要 目的:探索一种微孔膜渗透泵型胶囊剂的制备方法并研究其释药行为的影响因素,为开发该渗透泵控释制剂奠定基础。方法:以乙酸纤维素为囊膜材料,PEG-400为增塑剂,PEG-2000为致孔剂,采用蘸胶工艺制备胶囊壳,并考察不同的致孔剂用量、内容物促渗剂种类等研究其对对乙酰氨基酚释药行为的影响,通过维拉帕米和沙格雷酯来验证微孔膜胶囊的控释效果,并通过扫描电镜对囊壳表面及断面进行观察。结果:选择不同的致孔剂用量或调节囊内配方,均可使胶囊控制药物在规定时间内缓慢释放。结论:微孔膜渗透泵型胶囊比传统渗透泵控释片优点多,有望发展成为一种新型控释给药系统。 Objective: To prepare porous membrane osmotic pump capsules and investigate the factors influencing release behavior.Methods: With cellulose acetate(CA)as capsule materials,PEG-400 and PEG-2000 as plasticizer and pore former,shell of osmotic pump capsules was prepared by dip plastic method.Different pore-forming materials and osmogents influencing release behavior were investigated with paracetamol as a model drug and the factors were identified by werapamil hydrochloride and sarpogrelate hydrochloride.surface and cross-section of capsule shell were also studied under scanning electron microscope.Results: Porosity membrane osmotic pump capsules can control the release of drug during a desired time according to optimise the pore former contents and osmogents,respectively.Conclusion: Porous membrane osmotic pump capsules enjoy more advantages than ordinary osomotic tablets,which showed poten-tial to be a new controlled-release drug delivery system.
出处 《温州医学院学报》 CAS 2011年第2期161-164,167,共5页 Journal of Wenzhou Medical College
基金 温州市科技局科研基金资助项目(S20100042) 平阳县科技局科研基金资助项目(AS201003) 浙江省大学生科技创新活动计划资助项目(2010R413004)
关键词 渗透泵 微孔膜胶囊 控制释药 osmotic pump porous membrane capsule controlled drug release
  • 相关文献

参考文献10

  • 1Zentner GN,Rork GS,Himmelstein KJ.The controlled porosity osmotic pump[J].J Controlled Release,1985,1(4):269-282.
  • 2Makhija SN,Vavia PR.Controlled porosity osmotic pumpbased controlled release systems of pseudoephedrine I.Cellulose acetate as a semipermeable membrane[J].J Controlled Release,2003,89(1):5-18.
  • 3Rajeshri W,Varma MM.Once a day osmotic drug delivery system for highly water soluble Pramipexole[J].J Chem Pharm Res,2010,2(2):136-146.
  • 4Thombre AG,Cardina JR,DeNoto AR,et al.Asymmetric membrane capsules for osmotic.drug delivery I-Development of a manufacturing process[J].J Controlled Release,1999,57(1):55-64.
  • 5Philip AK.Osmotically regulated flow of flurbiprofen through in situ formed asymmetric membrane capsule[J].Current Drug Delivery,2008,5(2):127-132.
  • 6潘卫三,李孝栋.将普通胶囊制成渗透泵胶囊新剂型的方法:中国,02109221.4[P].2002-09-25.
  • 7傅红兴,曹高忠,胡明釵,等.一种渗透泵控释胶囊壳及其制备方法.CP,CN101301281[P].2008-11-12.
  • 8万常伟,傅红兴,徐艳艳,赵应征,杨栋,曹高忠.渗透泵控释胶囊的制备与释药影响因素研究[J].医药导报,2010,29(4):511-515. 被引量:9
  • 9曹高忠,傅红兴,张福志,朱新波,汤从容,张秀华,赵艳花.盐酸沙格雷酯渗透泵控释片的研制[J].中国医院药学杂志,2008,28(13):1055-1058. 被引量:7
  • 10Theeuwes F.Elementary osmotic pump[J].J Pharm Sci,1975,64(12):1987-1991.

二级参考文献13

共引文献14

同被引文献36

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部